To test this idea and investigate whether the membrane content of DGC is influenced by the fall in PI3K-Akt signaling, we used transgenic mouse  (MKR) model for type 2 diabetes, which express a kinase-inactive form of IGF-1 receptor (IGF-1R) specifically in skeletal muscle. This evidence concerns the gene AKT1 and type 2 diabetes mellitus.